Organigram Holdings Inc. NASDAQ (OGI), TSX Venture (OGI), is the parent company of Organigram Inc., a leading Canadian licensed producer (LP) of premium quality cannabis and extract-based products. Founded in 2013, Organigram first began as a medical cannabis provider. Today, the Company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. The Company has the lowest cultivation cost per gram¹harvested among publicly reporting Canadian LPs primarily attributable to high yields and operational efficiencies driven by a relentless culture of continuous improvement and the use of a unique and proprietary software system, OrganiGrow.

Organigram is focused on translating operational excellence into strong financial results and return on investment for shareholders.

¹Cultivation cost per gram is a non-IFRS performance measure which is not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies.  Please see the Company’s latest MD&A in the “Financial Reports” section under “Investors” tab of this website.